CadheRx Therapeutics Overview
- Founded
-
2014
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
CadheRx Therapeutics General Information
Description
Developer of therapeutic antibodies designed to target and cure solid tumors. The company's antibodies are used in the treatment of solid tumors that are resistant to other treatments, particularly Cetuximab and Herceptin resistant epithelial cancers, enabling patients to remove solid tumors without surgery.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
- 11099 North Torrey Pines Road
- Suite 290
- San Diego, CA 92037
- United States
CadheRx Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 04-Apr-2017 | 0000 | Completed | Out of Business | ||
| 1. Early Stage VC (Series A) | 15-Jun-2015 | 0000 | 0000 | Completed | Startup |